Rare Clinical Spotlight

Exploring Castleman Disease, Cold Agglutinin Disease, and Acute Intermittent Porphyria CME/CNE/CPE

Hyatt Regency Orlando
Friday, December 5, 2025 | 11:30 AM - 1:00 PM TZ
event presence logo
Supported by an independent educational grant from Recordati Rare Diseases.

overview

Join us for this unique 90-minute symposium which will showcase three rare hematologic diseases, Castleman disease (CD), cold agglutinin disease (CAD), and acute intermittent porphyria (AIP), with the shared expertise of 6 faculty that treat these rare diseases! Faculty for each disease area, will present compelling cases with interactive polling questions as a platform to weave in clinical decision-making points for improving patient outcomes. Learn what drives these diseases by understanding their pathophysiology and subsequently how to recognize signs and symptoms to properly diagnose these rare patients. Current and emerging treatment options will be presented, and faculty will disseminate key efficacy and safety data to help you understand how to choose optimal treatment approaches for patients. Take advantage of this opportunity to engage with and ask these expert faculty your important questions and walk away with more knowledge for treating patients with these diseases. Don’t miss this one!

Friday Satellite Symposium on Hematology, preceding the 67th ASH Annual Meeting and Exposition

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

​​Catherine Broome, MD

​Hematologist

​MedStar Georgetown Cancer Institute

​MedStar Georgetown University Hospital

​Washington, DC

​​Angelika Erwin, MD

​Interim Medical Director, Center for Personalized Genetic Healthcare

​Cleveland Clinic

​Cleveland, Ohio

​Founder and Director, MyGeneticist

​Miami, Florida​

​​Sudipto Mukherjee, MD, PhD, MPH

​Assistant Professor, Lerner College of Medicine at CWRU

​Director, Rare Cancers and Blood Diseases

​Chair, Protocol Review Monitoring Committee

Case Comprehensive Cancer Center

​Cleveland Clinic Taussig Cancer Institute 

​Department of Hematology and Medical Oncology

​Cleveland, Ohio

​​Ariela Noy, MD

​Attending Physician

​Member of Lymphoma Service

​Memorial Sloan Kettering Cancer Center

​New York, New York

​​Bruce Wang, MD

​Associate Professor

Division of Gastroenterology

Director, UCSF Porphyria Center

University of California

San Francisco, California​

​​Ilene Weitz, MD

​Associate Professor, Clinical Medicine

​Keck School of Medicine, University of Southern California (USC)

​Los Angeles, California​

AGENDA

5:43 AM TZ

backstage pass
Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video encouraged*

LOCATION

Hyatt Regency Orlando

9801 International Drive, Orlando, Florida, 32819

Room: Plaza International HIJK

TARGET AUDIENCE

This educational activity is intended for an audience of hematologists/oncologists, rheumatologists, nephrologists, infectious disease/HIV specialists, pulmonologists, allergists/clinical immunologists, emergency medicine physicians, neurologists, gastroenterologists, and hematology/oncology nurses in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to assess clinical data and how these may be applied to management decisions in rare hematologic diseases, including CD, CAD, and AIP.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have increased knowledge regarding the[/para] [list][item]Treatment options for patients with rare hematologic diseases [/list] [para]Have greater competence related to[/para] [list][item]Diagnosing a patient with a rare hematologic disease [item]Creating tailored treatment plans for patients with rare hematologic diseases [/list] [para]Demonstrate greater confidence in their ability to[/para] [list][item]Highlight best practices for optimization of care for patients with rare hematologic diseases [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
accreditation logo
medscape logo
[title]For Physicians[/title] [text]Medscape, LLC designates this live activity for a maximum of 1.50 [bold][italic]AMA PRA Category 1 Credit(s)[/italic][super]TM[/super][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[/text] [break] [title]For Nurses[/title] [text]Awarded up to 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs.[/text] [break] [title]For Pharmacists[/title] [text]Medscape designates this continuing education activity for ​1.50​ contact hour(s) (​0.150​ CEUs)[/text]
© 2025 MedscapeLIVE! All Rights Reserved | Medscape Education Terms of Service | Privacy Policy